Imperial College London
Portrait Picture

Dr Sabine L. van Elsland

Faculty of Medicine, School of Public Health

External Relationships & Communications Manager
 
 
 
//

Contact

 

+44 (0)20 7594 3896s.van-elsland

 
 
//

Location

 

G35Medical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@techreport{Olivera:2021:10.25561/87096,
author = {Olivera, Mesa D and Hogan, A and Watson, O and Charles, G and Hauck, K and Ghani, A and Winskill, P},
doi = {10.25561/87096},
title = {Report 43: Quantifying the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic},
url = {http://dx.doi.org/10.25561/87096},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - RPRT
AB  - Vaccine hesitancy – a delay in acceptance or refusal of vaccines despite availability 1 – has the potential to threaten the successful roll-out of SARS-CoV-2 vaccines globally 2 . Here, we evaluate the potential impact of vaccine hesitancy on the control of the pandemic and the relaxation of non-pharmaceutical interventions (NPIs) by combining an epidemiological model of SARS-CoV-2 transmission 3 with data on vaccine hesitancy from population surveys. Our findings suggest that the mortality over a 2-year period could be up to 8 times higher in countries with high vaccine hesitancy compared to an ideal vaccination uptake if NPIs are relaxed. Alternatively, high vaccine hesitancy could prolong the need for NPIs to remain in place. Addressing vaccine hesitancy with behavioural interventions is therefore an important priority in the control of the COVID-19 pandemic.
AU  - Olivera,Mesa D
AU  - Hogan,A
AU  - Watson,O
AU  - Charles,G
AU  - Hauck,K
AU  - Ghani,A
AU  - Winskill,P
DO  - 10.25561/87096
PY  - 2021///
TI  - Report 43: Quantifying the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic
UR  - http://dx.doi.org/10.25561/87096
UR  - https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2021-03-24-COVID19-Report-43.pdf
UR  - http://hdl.handle.net/10044/1/87096
ER  -
Download